Stay updated on Selinexor Combo for High-Risk Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.

Latest updates to the Selinexor Combo for High-Risk Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe website footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check25 days agoChange DetectedA notice about NIH’s terminology transition appears near the top of the page, linking to updates and FAQs.SummaryDifference0.6%

- Check32 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the platform as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check39 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check60 days agoChange DetectedThe latest version adds Results Posted, Adverse Events, and Outcome Measures (Results) along with an updated Study Status and revision v3.7.0. Previously listed items like Results Submitted and Revision: v3.6.6 have been removed, indicating a transition from submission to public posting of trial results.SummaryDifference0.7%

- Check81 days agoChange DetectedThe revision history now shows a new entry for v3.6.6 and removes the previous v3.6.5 entry, updating the page's revision log to reflect the latest version.SummaryDifference0.1%

Stay in the know with updates to Selinexor Combo for High-Risk Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.